Rusinaru Dan, Saaidi Imen, Godard Stephanie, Mahjoub Haïfa, Battle Caroline, Tribouilloy Christophe
INSERM, ERI 12 and University Hospital Amiens, Amiens, France.
Am J Cardiol. 2008 Feb 1;101(3):353-8. doi: 10.1016/j.amjcard.2007.08.046. Epub 2007 Dec 21.
Chronic obstructive pulmonary disease (COPD) is a frequently neglected co-morbidity in patients with heart failure (HF). The aim of this study was to evaluate the prognostic impact of COPD in patients hospitalized for HF. Consecutive patients (n=799) admitted for a first episode of HF in all healthcare establishments of the Somme department (France) during 2000 were prospectively enrolled. Baseline characteristics and long-term prognosis were compared according to COPD status. COPD was diagnosed in 156 patients (19.5%). Compared with the no-COPD group, patients with COPD were predominantly men, more often smokers, and had lower discharge prescription rates of beta blockers (6% vs 27%, p<0.001). Five-year survival rate in patients with COPD was significantly lower than that of the no-COPD group (31% vs 42%, p=0.03). Compared with the expected survival of the age- and gender-matched general population, the 5-year survival rate in patients with COPD was dramatically lower (31% vs 71%). On multivariable analysis, COPD was a strong predictor of poorer outcome (hazard ratio 1.53, 95% confidence interval 1.21 to 1.94, p<0.001). COPD was an independent predictor of mortality in patients with preserved left ventricular ejection fraction and in patients with reduced ejection fraction. In conclusion, patients with HF and associated COPD have a poor prognosis with an impressive excess mortality compared to HF patients without COPD and the general population. Beta-blocker prescription rates remain deceptively low in this category of patients with HF.
慢性阻塞性肺疾病(COPD)是心力衰竭(HF)患者中一种经常被忽视的合并症。本研究的目的是评估COPD对因HF住院患者预后的影响。前瞻性纳入了2000年在法国索姆省所有医疗机构因首次发作HF入院的连续患者(n = 799)。根据COPD状态比较基线特征和长期预后。156例患者(19.5%)被诊断为COPD。与无COPD组相比,COPD患者以男性为主,吸烟者更多,β受体阻滞剂出院处方率更低(6%对27%,p<0.001)。COPD患者的5年生存率显著低于无COPD组(31%对42%,p = 0.03)。与年龄和性别匹配的普通人群的预期生存率相比,COPD患者的5年生存率显著更低(31%对71%)。多变量分析显示,COPD是预后较差的有力预测因素(风险比1.53,95%置信区间1.21至1.94,p<0.001)。COPD是左心室射血分数保留患者和射血分数降低患者死亡率的独立预测因素。总之,与无COPD的HF患者和普通人群相比,合并COPD的HF患者预后较差,死亡率显著过高。在这类HF患者中,β受体阻滞剂的处方率仍然低得惊人。
Int J Cardiol. 2008-5-23
J Card Fail. 2010-1-6
G Ital Cardiol (Rome). 2007-9
Int J Cardiol. 2008-12-18
J Am Heart Assoc. 2022-4-5